The global orthobiologics market reached USD 7.8 billion in 2023 and is projected to grow to USD 15.9 billion by 2032, expanding at a CAGR of 8.1% during 2024–2032. Growth is fueled by the rising prevalence of musculoskeletal disorders, increasing sports injuries, aging population, and growing adoption of minimally invasive regenerative therapies. North America currently leads the market...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek